Summary:
Clinical Research Professionals is conducting a phase 3, 52 week study for a combination of up to three already approved medications for COPD. The study drug will be in different combinations given through a mouth inhaler.
The purpose of the study is to see if these combinations of drugs decrease or prevent COPD flare ups.
Qualified Participants Must:
• Be at least 40 years of age
•
Have been diagnosed with COPD
•
Be on a stable dose of COPD medications for at least 3 months
•
If female, be surgically sterile or post-menopausal for at least one year
•
Be a smoker or have a history of smoking
•
Not currently have asthma but can have a history of asthma
•
Have had at least one episode of severe COPD in the past 12 months
•
Not have any major disorders such as HIV, lupus, Parkinson's disease, tuberculosis, lung cancer, or pulmonary hypertension
•
Not be on over 3L (liters) of oxygen
•
Not have cancer in the past five years (skin cancer is ok)
•
Not have had issues with drug or alcohol abuse in the past 2 years